What we do

Oxartis is focussed on transforming the lives of patients who have suffered from significant tissue loss, through introducing a new concept in tissue regeneration.

We have developed an innovative technology for producing 3-dimension biomaterials with a nano-scale base structure. These are tissue scaffold materials which interact with the body’s cells and tissues to promote integration by formation of blood capillaries.

We also offer scaffold biomaterials and custom manufacture for innovative tissue scaffold research.

Our VISION

Our vision is to transform the reconstruction of lost tissue, through a portfolio of next-generation regenerative tissue engineering products for skin, soft tissue and bone reconstruction, guided by in-depth knowledge of regenerative medicine and biological manufacturing.

We are innovators aiming to transform the healing process through novel regenerative tissue reconstruction solutions.

We provide value to the ecosystem of patient, clinician and payers.

Patients’ lives matter to us and lies at the heart of our vision. 

Our MISSION

Our mission is to solve an urgent un-met clinical need for an off-the-shelf regenerative scaffold for severe skin injuries, by introducing a novel scaffold technology which accelerates skin reconstruction, to improve outcomes for patients with skin-loss wounds.

What We've Achieved

• Created ProMatrix BioDerm, a tissue scaffold for regenerative reconstruction of deep skin loss wounds

• Developed a unique, scalable, rapid manufacturing process for skin regeneration scaffolds

• Won an Innovate UK Biomedical Catalyst grant to support ProMatrix BioDerm commercialisation

• Protected our IP through patenting and established a robust development strategy

• Formed partnerships with major university hospitals in Europe & the UK

• Built a strong team to develop our core technology through to clinical use